Pharmacoeconomic aspects of the targeted drugs use in psoriatic arthritis in context of the Russian healthcare system by O. I. Ivakhnenko, T. V. Korotaeva, T. V. Dubinina, A. M. Lila

Get full text

Clinical and economic evaluation of the use of biologic disease-modifying antirheumatic drugs and targeted synthetic antirheumatic drugs for ankylosing spondylitis in context of th... by O. I. Ivakhnenko, T. V. Dubinina, T. V. Korotaeva, A. M. Lila

Get full text

Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens by D. V. Fedyaev, R. V. Gostishchev, V. A. Lemeshko, O. I. Ivakhnenko

Get full text

Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome by O. I. Ivakhnenko, E. V. Derkach, V. S. Krysanova, A. D. Ermolaeva, K. A. Kokushkin

Get full text

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS by V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko

Get full text

Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 by V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan

Get full text